Jan ter Meulen
2017
In 2017, Jan ter Meulen earned a total compensation of $950.6K as Chief Scientific Officer at Immune Design, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $155,000 |
|---|---|
| Option Awards | $273,129 |
| Salary | $388,624 |
| Stock Awards | $123,200 |
| Other | $10,600 |
| Total | $950,553 |
ter Meulen received $388.6K in salary, accounting for 41% of the total pay in 2017.
ter Meulen also received $155K in non-equity incentive plan, $273.1K in option awards, $123.2K in stock awards and $10.6K in other compensation.
Rankings
In 2017, Jan ter Meulen's compensation ranked 9,205th out of 14,666 executives tracked by ExecPay. In other words, ter Meulen earned more than 37.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,205 out of 14,666 | 37th |
Division Manufacturing | 3,540 out of 5,772 | 39th |
Major group Chemicals And Allied Products | 1,214 out of 2,075 | 42nd |
Industry group Drugs | 975 out of 1,731 | 44th |
Industry Pharmaceutical Preparations | 766 out of 1,333 | 43rd |
Source: SEC filing on April 26, 2018.
ter Meulen's colleagues
We found two more compensation records of executives who worked with Jan ter Meulen at Immune Design in 2017.